STOCKHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

Summary of stock option activity

	Outstanding Options			Weighted average exercise price		Weighted average remaining contractual term		Aggregate Intrinsic Value
Outstanding at December 31, 2022		38,926		$	46.75		2.20	$	10.50
Granted		-			-		-		-
Exercised		-			-		-		-
Forfeited		(38,926	)		46.75		-		-
Outstanding at December 31, 2023		-		$	-		-	$	-
Outstanding at December 31, 2024		-
Exercisable at December 31, 2024		-		$	-		-	$	-

Schedule of restricted stock units

				Weighted
				Average Grant Date
	Units			Fair value
Unvested at December 31, 2022		44,516		$	23.75
Granted		14,831			5.39
Vested		(20,498	)		(21.63	)
Forfeited		(38,849	)		(17.86	)
Unvested at December 31, 2023		-		$	-

Schedule of stock based compensation expense

	Years ended December 31,
	2024		2023
Cost of goods sold	$	-	$	17,205
Sales and marketing		-		55,657
General and administrative		897,163		75,921
Research and development		-		130,612
Total stock-based compensation expense	$	897,163	$	279,395